In toxicology, ICH plays a pivotal role by providing guidelines that help standardize the assessment of potential risks associated with pharmaceuticals. The harmonisation of toxicological testing methods ensures that data generated in one region is acceptable in others, thereby facilitating the global drug development process. This ultimately helps in minimizing the risk of inconsistent safety assessments and regulatory submissions, which can delay the availability of new therapies.
